
Astria Therapeutics (ATXS) Earnings Dates & Reports
Astria Therapeutics (ATXS) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS-$0.42
Actual EPS-$0.55
EarningsMiss
Astria Therapeutics (ATXS) Earnings
View the latest Astria Therapeutics (ATXS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Astria Therapeutics (ATXS)
Order type
Buy in
Order amount
Est. shares
0 shares
Astria Therapeutics (ATXS) Earnings per Share (EPS) History
Signup for full accessBrowse free
Astria Therapeutics (ATXS) Latest Earnings
The value each ATXS share was expected to gain vs. the value each share gained.
Astria Therapeutics (ATXS) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.55. This exceeded analysts' expectations of -$0.42 by 30.95%, marking a Miss.
For comparison, Astria Therapeutics reported EPS of -$0.42 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.51.
Astria Therapeutics (ATXS) Earnings History
Astria Therapeutics (ATXS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Astria Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Astria Therapeutics (ATXS) Earnings FAQs
Astria Therapeutics (ATXS) last reported earnings on Nov 12, 2025 for Q3 2025, posting an EPS of -$0.55, which Miss the estimate of -$0.42 by 30.95%.
For Q3 2025, Astria Therapeutics (ATXS) reported an EPS of -$0.55, missing analysts' estimate of -$0.42 by 30.95%.
For Q3 2025, Astria Therapeutics (ATXS) Miss expectations with an actual EPS of -$0.55 vs. an estimated EPS of -$0.42.
Following the last earnings report on Nov 12, 2025, Astria Therapeutics (ATXS)'s stock price moved — from — to —.
The next Astria Therapeutics (ATXS) earnings call is scheduled for Mar. 10, 2026, where executives will discuss financial results and outlook.